About Oncovision
Oncovision is a company based in Boston (United States) founded in 2003 by Noriel Pavon was acquired by Bruker in September 2016.. Oncovision has raised $3.84 million across 9 funding rounds from investors including Bruker, European Union and EIC Fund. Oncovision offers products and services including Mammi, Sentinella, Wprobe, and Caremibrain. Oncovision operates in a competitive market with competitors including Siemens Healthineers, Vayyar, Olympus, Niramai and Lantheus, among others.
- Headquarter Boston, United States
- Founders Noriel Pavon
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Oncovision, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Oncovision
Oncovision offers a comprehensive portfolio of products and services, including Mammi, Sentinella, Wprobe, and Caremibrain. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides precise imaging for breast cancer detection and diagnosis.
Assists in locating sentinel lymph nodes during cancer procedures.
Enables accurate detection for practical medical imaging applications.
Supports diagnosis and monitoring of Alzheimer's disease effectively.
Funding Insights of Oncovision
Oncovision has successfully raised a total of $3.84M across 9 strategic funding rounds. The most recent funding activity was a Grant round of $337.8 thousand completed in September 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Grant — $337,799
- First Round First Round
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2023 | Amount | Grant - Oncovision | Valuation |
investors |
|
| May, 2019 | Amount | Grant - Oncovision | Valuation |
investors |
|
| Jun, 2016 | Amount | Grant - Oncovision | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Oncovision
Oncovision has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Bruker, European Union and EIC Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location | |
|
A private venture capital firm focused on life sciences investments.
|
Founded Year | Domain | Location | |
|
ICO Axispart is engaged in providing financial solutions for businesses.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Oncovision
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Oncovision
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Oncovision Comparisons
Competitors of Oncovision
Oncovision operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Siemens Healthineers, Vayyar, Olympus, Niramai and Lantheus, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
AI-based medical diagnostics are developed for healthcare applications.
|
|
| domain | founded_year | HQ Location |
Developer of 4D imaging sensors for cancer detection and other devices
|
|
| domain | founded_year | HQ Location |
Manufacturer of imaging and surgical products
|
|
| domain | founded_year | HQ Location |
Early breast cancer is detected using AI-based non-invasive thermal imaging.
|
|
| domain | founded_year | HQ Location |
Developer of diagnostic imaging agents and targeted therapeutics
|
|
| domain | founded_year | HQ Location |
Developer of diagnostic imaging and healthcare information technology systems for hospital use
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Oncovision
Frequently Asked Questions about Oncovision
When was Oncovision founded?
Oncovision was founded in 2003 and raised its 1st funding round 3 years after it was founded.
Where is Oncovision located?
Oncovision is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Is Oncovision a funded company?
Oncovision is a funded company, having raised a total of $3.84M across 9 funding rounds to date. The company's 1st funding round was a Grant of $4.92M, raised on Jun 01, 2006.
What does Oncovision do?
Oncovision was founded in 2003 and is headquartered in Boston, United States. Medical and diagnostic devices focused on oncology imaging are produced by the company. Key product lines include the Sentinella intra-operative Gamma Camera and the MAMMI PET system, which enables visualization of small lesions and quantification of tumor activity in breast cancer diagnostics. Operations center on advancing oncology detection technologies.
Who are the top competitors of Oncovision?
Oncovision's top competitors include Olympus, Siemens Healthineers and United Imaging Healthcare.
What products or services does Oncovision offer?
Oncovision offers Mammi, Sentinella, Wprobe, and Caremibrain.
Who are Oncovision's investors?
Oncovision has 6 investors. Key investors include Bruker, European Union, EIC Fund, CRB Inverbio, and ICO Axispart.